JAGX (Jaguar Animal Health) Pangali Forward P/E

Lambang korporat lan logo Jaguar Health Inc (JAGX)

Jaguar Health, Inc. (JAGX) current forward P/E ratio demonstrates the impact of the company's ESG strategy to develop eco-friendly medications from tropical plants. The 0.00 metric captures the current state of this parameter amid geopolitical risks limiting the export of gastrointestinal segment drugs. A strong staff of botanists and specialized researchers supports business stability, minimizing the internal attrition of valuable scientific personnel.

JAGX - Kapitalisasi marang proyeksi bathi Jaguar Health Inc ing rentang 04.07.2022 - 17.11.2026

Rincian metrik komprehensif lan analitis Jaguar Health, Inc. (JAGX)

Analisis komprehensif perusahaan:Jaguar Health Inc
Produk mawa merek Jaguar Health Corp

Stable capacity utilization of production lines for gastroenterological products provides Jaguar Health, Inc. (JAGX) with predictable cash flows, which is critical for assessing the issuer's financial stability. The company's consensus forward P/E, calculated as the ratio of current market capitalization to expected earnings, allows this chart to determine the degree of business overvaluation relative to future income and identify the mathematical potential for share price growth.